No Data
Iron Drugs Industry Forecast Report, 2028: Includes Strategic Analyses of McKesson, Sanofi, GlaxoSmithKline (GSK), Rockwell Medical, Shield Therapeutics, and Pharmacosmos
GlaxoSmithKline's (GSK.US) PD-1 antibody has been approved for listing in Singapore.
On August 7th, GlaxoSmithKline (GSK.US) Singapore announced that the Health Sciences Authority (HSA) of Singapore has approved a new indication for Jemperli (dostarlimab).
Argus Research Remains a Buy on GlaxoSmithKline (GSK)
New Drugs and Cost Controls Fuel Wave of Pharma Guidance Lifts -- Analysis
Top Gap Ups and Downs on Tuesday: UBER, ZTS, GSK and More
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
No Data
